EUVIMEDEUVIMED entdecken
Crossref

Arenarine D Promotes Pancreatic β Cell Proliferation Via DYRK1A Inhibition for T1DM Therapy

Chen Wang, Qing Huang, Shuo Gao iD, Qian Zhu, Ting Lin

Chemistry & Biodiversity · 2026-03 · 23 (3)

DOI: 10.1002/cbdv.71132 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 23.03.2026. Verfasst von Chen Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Fujian Provincial Key Laboratory of Innovative Drug Target Research, Xiamen University, Xiamen, China. Hauptthemen laut MEDLINE: Insulin-Secreting Cells, Protein Serine-Threonine Kinases, Diabetes Mellitus, Type 1, Diabetes Mellitus, Experimental. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes is a complex and refractory metabolic disease severely threatening human health. A common feature of both type 1 and advanced type 2 diabetes is the failure and loss of functional β‐cells. Stimulating pancreatic β cell proliferation for endogenous regeneration represents the most direct therapeutic approach.Through screening of secondary metabolites from the endophytic fungus of Ajuga decumbens Thunb using a zebrafish model, we identified Arenarine D promoting β cell regeneration. In a low‐dose STZ‐induced T1DM mouse model, Arenarine D treatment lowered blood glucose and improved insulin resistance. Importantly, we found it promotes mouse β cell proliferation by inhibiting DYRK1A. To our knowledge, we are the first to report that Arenarine D can promote the proliferation of pancreatic β cells by inhibiting DYRK1A, and this effect stems from the replication of existing β cells rather than other pathways. This demonstrates the great potential of Arenarine D in the treatment of T1DM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin-Secreting CellsProtein Serine-Threonine KinasesDiabetes Mellitus, Type 1Diabetes Mellitus, ExperimentalProtein Kinase InhibitorsAnimalsDyrk KinasesCell ProliferationProtein-Tyrosine KinasesMiceZebrafishHumansStreptozocin

Stichwörter der Autor:innen

T1DMarenarine Ddiabetesβ cell proliferation

Substanzen

Dyrk KinasesProtein Serine-Threonine KinasesProtein-Tyrosine KinasesProtein Kinase InhibitorsStreptozocin

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Fujian Provincial Key Laboratory of Innovative Drug Target Research, Xiamen University, Xiamen, China.

ORCID-Profile: Shuo Gao

Förderung

  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Wang, C., Huang, Q., Gao, S., Zhu, Q., & Lin, T. (2026). Arenarine D Promotes Pancreatic β Cell Proliferation Via DYRK1A Inhibition for T1DM Therapy. Chemistry & Biodiversity, 23(3). https://doi.org/10.1002/cbdv.71132

Vancouver

Wang C, Huang Q, Gao S, Zhu Q, Lin T. Arenarine D Promotes Pancreatic β Cell Proliferation Via DYRK1A Inhibition for T1DM Therapy. Chemistry & Biodiversity. 2026;23(3). doi:10.1002/cbdv.71132

BibTeX
@article{Wang2026,
  author = {Wang, Chen and Huang, Qing and Gao, Shuo and Zhu, Qian and Lin, Ting},
  title = {Arenarine D Promotes Pancreatic β Cell Proliferation Via DYRK1A Inhibition for T1DM Therapy},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  volume = {23},
  number = {3},
  doi = {10.1002/cbdv.71132}
}
Kostenlos starten →